Get Regular Updates!




Nik Bappoo: Healthcare for all

Nik Bappoo: Healthcare for all

WA Science Student of the Year Nikhilesh Bappoo on addressing inequities in healthcare access.

Nik Bappoo: Healthcare for all

If you’ve ever been admitted to hospital, you’ve probably had it.

Cannulation – inserting a drip to draw blood or deliver medication – is one of the most common procedures in Australian hospitals.

But the first attempt at cannulation fails about 40% of the time. For children and chemotherapy patients, the failure rate is up to 70%.

It’s a problem biomedical engineer and UWA PhD candidate Nikhilesh Bappoo aims to solve.


Nik, who was recently named WA’s Student Scientist of the Year at the Premier’s Science Awards, is an expert in how blood flows through the body.

Nik Bappoo

He’s also the co-founder and chief technology officer of VeinTech, a startup that aims to help clinicians hit the vein first time, every time.

The company has developed a mobile phone-sized device that doctors and nurses place against a patient’s arm to find the vein.



“It’s an ultrasound-based technology,” says Nik, “so it continuously emits sound waves and receives those sound waves back.

“We’ve developed some [artificial intelligence tools] to process those signals … and then display those signals in a way that’s understandable by anyone.”

Nik says the design removes the complexity and training requirement of standard ultrasound machines.

“[We’ve] made it ‘ultrasound for dummies’ in a way,” he says. “I could pick it up and find a vein.”


Growing up on the island of Mauritius, Nik saw firsthand how a lack of access to healthcare, technology and education impacted his loved ones.

After moving to Australia, Nik still saw unmet clinical needs and barriers to access, particularly while volunteering in rural WA.

These observations have driven him to use his passion for science, engineering and medicine to reduce those inequalities.

Much of Nik’s research has been simulating blood flow in the placenta and understanding causes of aneurysms.

View Larger
Image|Nik Bappoo
The VeinWave unit is designed to help visualise veins

He was previously involved in VitalTrace, a WA company developing new fetal monitoring technology.

Nik admits moving from pure research to commercialising tech has been a steep learning curve. But his scientific mindset has proven useful in business.

“The integrity and the rigour you have to have as a scientist is exactly the same when you’re running a business and trying to raise investment or apply for grants to fund your work,” says Nik.

“A lot of assumptions that you have in business – like is your customer going to buy this product for X price – you validate them very scientifically.”


Nik’s found it useful to have mentors in world-leading medical researchers who turned their ideas into products.

His advice for young researchers looking to commercialise their ideas is to spend 80–90% of their time trying to truly understand the problem they hope to solve.

“The traditional way of doing research is you just go and do something based on what the literature might suggest or what your interests are,” says Nik.

“And then you try to retrospectively fit it to a real-world application.

“My personal philosophy is starting with a need … and then using that as the launching pad to do the research.”

Nik believes understanding why you want to do the research is the most powerful tool.

“Where does that passion come from? Why do you want to make this impact in this field?” asks Nik.

“Having that crystal clear from the get-go is probably one of the most useful things I’ve done.

“Because research and commercialisation – it’s tough. And knowing why you’re doing what you’re doing is quite useful when things get hard.”

Particle Puns


Creative Commons Logo

Republishing our content

We want our stories to be shared and seen by as many people as possible.

Therefore, unless it says otherwise, copyright on the stories on Particle belongs to Scitech and they are published under a Creative Commons Attribution-NoDerivatives 4.0 International License.

This allows you to republish our articles online or in print for free. You just need to credit us and link to us, and you can’t edit our material or sell it separately.

Using the ‘republish’ button on our website is the easiest way to meet our guidelines.


You cannot edit the article.

When republishing, you have to credit our authors, ideally in the byline. You have to credit Particle with a link back to the original publication on Particle.

If you’re republishing online, you must use our pageview counter, link to us and include links from our story. Our page view counter is a small pixel-ping (invisible to the eye) that allows us to know when our content is republished. It’s a condition of our guidelines that you include our counter. If you use the ‘republish’ then you’ll capture our page counter.

If you’re republishing in print, please email us to let us so we know about it (we get very proud to see our work republished) and you must include the Particle logo next to the credits. Download logo here.

If you wish to republish all our stories, please contact us directly to discuss this opportunity.


Most of the images used on Particle are copyright of the photographer who made them.

It is your responsibility to confirm that you’re licensed to republish images in our articles.


All Particle videos can be accessed through YouTube under the Standard YouTube Licence.

The Standard YouTube licence

  1. This licence is ‘All Rights Reserved’, granting provisions for YouTube to display the content, and YouTube’s visitors to stream the content. This means that the content may be streamed from YouTube but specifically forbids downloading, adaptation, and redistribution, except where otherwise licensed. When uploading your content to YouTube it will automatically use the Standard YouTube licence. You can check this by clicking on Advanced Settings and looking at the dropdown box ‘License and rights ownership’.
  2. When a user is uploading a video he has license options that he can choose from. The first option is “standard YouTube License” which means that you grant the broadcasting rights to YouTube. This essentially means that your video can only be accessed from YouTube for watching purpose and cannot be reproduced or distributed in any other form without your consent.


For more information about using our content, email us:

Copy this HTML into your CMS
Press Ctrl+C to copy

We've got chemistry. Want something physical?